Resultados globales: 16 registros encontrados en 0.03 segundos.
Artículos, Encontrados 11 registros
Documentos de investigación, Encontrados 5 registros
Artículos Encontrados 11 registros  1 - 10siguiente  ir al registro:
1.
8 p, 196.5 KB Comparison between MRI and pathology in the assessment of tumour regression grade in rectal cancer / Sclafani, Francesco (Department of Medicine, The Royal Marsden NHS Foundation Trust) ; Brown, Gina (Department of Radiology, The Royal Marsden NHS Foundation Trust) ; Cunningham, David (Department of Medicine, The Royal Marsden NHS Foundation Trust) ; Wotherspoon, Andrew (Department of Histopathology, The Royal Marsden NHS Foundation Trust) ; Mendes, Larissa Sena Teixeira (Department of Histopathology, The Royal Marsden NHS Foundation Trust) ; Balyasnikova, Svetlana (Department of Radiology, The Royal Marsden NHS Foundation Trust) ; Evans, Jessica (Department of Radiology, The Royal Marsden NHS Foundation Trust) ; Peckitt, Clare (Clinical Research & Development, The Royal Marsden NHS Foundation Trust) ; Begum, Ruwaida (Department of Medicine, The Royal Marsden NHS Foundation Trust) ; Tait, Diana (Department of Medicine, The Royal Marsden NHS Foundation Trust) ; Tabernero Caturla, Josep (Universitat Autònoma de Barcelona. Departament de Medicina) ; Glimelius, Bengt (Department of Immunology, Genetics and Pathology, Section of Experimental and Clinical Oncology, University of Uppsala) ; Roselló, Susana (Department of Haematology and Medical Oncology, Biomedical Research Institute INCLIVA, University of Valencia) ; Thomas, Janet (Department of Medicine, The Royal Marsden NHS Foundation Trust) ; Oates, Jacqui (Department of Medicine, The Royal Marsden NHS Foundation Trust) ; Chau, Ian (Department of Medicine, The Royal Marsden NHS Foundation Trust)
Limited data exist regarding the correlation between MRI tumour regression grade (mrTRG) and pathological TRG (pTRG) in rectal cancer. mrTRG and pTRG were compared in rectal cancer patients from two phase II trials (EXPERT and EXPERT-C). [...]
2017 - 10.1038/bjc.2017.320
British Journal of Cancer, Vol. 117 (09 2017) , p. 1478-1485  
2.
7 p, 828.5 KB Focused transhepatic electroporation mediated by hypersaline infusion through the portal vein in rat model : preliminary results on differential conductivity / Pañella, Clara (Institut Hospital del Mar d'Investigacions Mèdiques) ; Castellví, Quim (Universitat Pompeu Fabra. Departament de Tecnologies de la Informació i les Comunicacions) ; Moll, Xavier (Institut Hospital del Mar d'Investigacions Mèdiques) ; Quesada, Rita (Institut Hospital del Mar d'Investigacions Mèdiques) ; Villanueva, Alberto (Institut Català d'Oncologia) ; Iglesias, Mar (Universitat Autònoma de Barcelona. Departament de Medicina i Cirurgia Animals) ; Naranjo, Dolores (Universitat Autònoma de Barcelona. Departament de Medicina i Cirurgia Animals) ; Sánchez-Velázquez, Patricia (Institut Hospital del Mar d'Investigacions Mèdiques) ; Andaluz Martínez, Anna (Institut Hospital del Mar d'Investigacions Mèdiques) ; Grande, Luís (Institut Hospital del Mar d'Investigacions Mèdiques) ; Ivorra, Antoni (Universitat Pompeu Fabra. Departament de Tecnologies de la Informació i les Comunicacions) ; Burdío, Fernando (Institut Hospital del Mar d'Investigacions Mèdiques)
Spread hepatic tumours are not suitable for treatment either by surgery or conventional ablation methods. The aim of this study was to evaluate feasibility and safety of selectively increasing the healthy hepatic conductivity by the hypersaline infusion (HI) through the portal vein. [...]
2017 - 10.1515/raon-2017-0051
Radiology and oncology, Vol. 51, issue 4 (2017) , p. 415-421  
3.
18 p, 918.2 KB Coarse-graining and hybrid methods for efficient simulation of stochastic multi-scale models of tumour growth / Cruz Moreno, Roberto de la, (Universitat Autònoma de Barcelona. Departament de Matemàtiques) ; Guerrero Contreras, Pilar (Universitat Autònoma de Barcelona. Departament de Matemàtiques) ; Calvo, Juan (Universidad de Granada. Departmento de Matemática Aplicada) ; Alarcón Cor, Tomás (Centre de Recerca Matemàtica)
The development of hybrid methodologies is of current interest in both multi-scale modelling and stochastic reaction–diffusion systems regarding their applications to biology. We formulate a hybrid method for stochastic multi-scale models of cells populations that extends the remit of existing hybrid methods for reaction–diffusion systems. [...]
2017 - 10.1016/j.jcp.2017.09.019
Journal of computational physics, Vol. 350 (Dec. 2017) , p. 974-991  
4.
7 p, 814.0 KB Quality of life during first-line FOLFOX4±panitumumab in RAS wild-type metastatic colorectal carcinoma : results from a randomised controlled trial / Siena, Salvatore (Università degli Studi di Milano (Italy)) ; Tabernero Caturla, Josep (Vall d'Hebron Institut d'Oncologia (VHIO)) ; Bodoky, Gyorgy (Szent László Hospital (Hungary)) ; Cunningham, David (Royal Marsden National Health Service Foundation Trust (United Kingdom)) ; Rivera, Fernando (Hospital Universitario Marqués de Valdecilla (Santander)) ; Ruff, Paul (University of the Witwatersrand (South Africa)) ; Canon, Jean Luc (Grand Hôpital de Charleroi. Service d'Oncologie-Hématologie (Belgium)) ; Koukakis, Reija (Amgen Ltd. Department of Biostatistics (United Kingdom)) ; Demonty, Gaston (Amgen GmbH. Medical Development (Suïssa)) ; Hechmati, Guy (Amgen GmbH. Global Health Economics (Suïssa)) ; Douillard, Jean-Yves (Institut de Cancérologie de l'Ouest (France)) ; Universitat Autònoma de Barcelona
Metastatic colorectal cancer is rarely curable. Improving quality of life is therefore a key treatment goal. We report quality of life for patients with RAS wild-type metastatic colorectal cancer in the PRIME study. [...]
2016 - 10.1136/esmoopen-2016-000041
ESMO Open, Vol. 1, Issue 2 (March 2016) , art. e000041  
5.
12 p, 3.2 MB Dual loss of the SWI/SNF complex ATPases SMARCA4/BRG1 and SMARCA2/BRM is highly sensitive and specific for small cell carcinoma of the ovary, hypercalcaemic type / Karnezis, Anthony N (University of British Columbia. Department of Pathology and Laboratory Medicine) ; Wang, Yemin (University of British Columbia. Department of Pathology and Laboratory Medicine) ; Ramos, Pilar (Translational Genomics Research Institute (TGen). Division of Integrated Cancer Genomics) ; Hendricks, William PD (Translational Genomics Research Institute (TGen). Division of Integrated Cancer Genomics) ; Oliva, Esther (Massachusetts General Hospital. Department of Pathology) ; D'Angelo, Emanuela (Hospital de la Santa Creu i Sant Pau. Departament de Patologia) ; Prat, Jaime (Hospital de la Santa Creu i Sant Pau. Departament de Patologia) ; Nucci, Marisa R (Brigham and Women's Hospital. Department of Pathology) ; Nielsen, Torsten O (University of British Columbia. Department of Pathology and Laboratory Medicine) ; Chow, Christine (University of British Columbia. Genetic Pathology Evaluation Centre) ; Leung, Samuel (University of British Columbia. Genetic Pathology Evaluation Centre) ; Kommoss, Friedrich (Synlab MVZ Pathologie) ; Kommoss, Stefan (University Hospital of Tuebingen. Department of Obstetrics and Gynecology) ; Silva, Annacarolina (Harvard Medical School. The James Homer Wright Pathology Laboratories) ; Ronnett, Brigitte M (The Johns Hopkins Hospital. Department of Pathology) ; Rabban, Joseph T (University of California San Francisco. Department of Anatomic Pathology) ; Bowtell, David D (Peter MacCallum Cancer Centre) ; Weissman, Bernard E (University of North Carolina. Department of Pathology and Laboratory Medicine) ; Trent, Jeffrey M (Translational Genomics Research Institute (TGen). Division of Integrated Cancer Genomics) ; Gilks, C Blake (University of British Columbia. Department of Pathology and Laboratory Medicine) ; Huntsman, David G (University of British Columbia. Department of Pathology and Laboratory Medicine) ; Universitat Autònoma de Barcelona
Small cell carcinoma of the ovary, hypercalcaemic type () is a lethal and sometimes familial ovarian tumour of young women and children. We and others recently discovered that over 90% of harbour inactivating mutations in the chromatin remodelling gene with concomitant loss of its encoded protein (), one of two mutually exclusive of the / chromatin remodelling complex. [...]
2015 - 10.1002/path.4633
The Journal of Pathology, Vol. 238, Issue 3 (december 2015) , p. 389-400  
6.
18 p, 1.8 MB Targeting protein kinase CK2 : evaluationg CX-4945 potential for GL261 glioblastoma therapy in immunocompetent mice / Ferrer-Font, Laura (Universitat Autònoma de Barcelona. Departament de Bioquímica i Biologia Molecular) ; Villamañán de Santiago, Lucía (Universitat Autònoma de Barcelona. Departament de Bioquímica i Biologia Molecular) ; Arias-Ramos, Nuria (Universitat Autònoma de Barcelona. Departament de Bioquímica i Biologia Molecular) ; Vilardell Vilà, Jordi (Università degli studi di Padova. Dipartimento di Scienze Biomediche) ; Plana i Coll, Maria (Universitat Autònoma de Barcelona. Departament de Bioquímica i Biologia Molecular) ; Ruzzene, Maria (Università degli studi di Padova. Dipartimento di Scienze Biomediche) ; Pinna, Lorenzo A. (Università degli studi di Padova. Dipartimento di Scienze Biomediche) ; Itarte, Emili (Universitat Autònoma de Barcelona. Departament de Bioquímica i Biologia Molecular) ; Arús i Caraltó, Carles (Universitat Autònoma de Barcelona. Departament de Bioquímica i Biologia Molecular) ; Candiota Silveira, Ana Paula (Universitat Autònoma de Barcelona. Departament de Bioquímica i Biologia Molecular)
Glioblastoma (GBM) causes poor survival in patients even with aggressive treatment. Temozolomide (TMZ) is the standard chemotherapeutic choice for GBM treatment but resistance always ensues. Protein kinase CK2 (CK2) contributes to tumour development and proliferation in cancer, and it is overexpressed in human GBM. [...]
2017 - 10.3390/ph10010024
Pharmaceuticals, Vol. 10 Núm. 1 (2017) , p. art 24
2 documentos
7.
12 p, 942.4 KB BIM and mTOR expression levels predict outcome to erlotinib in EGFR-mutant non-small-cell lung cancer / Karachaliou, Niki (Hospital Universitari Quiron Dexeus (Barcelona, Catalunya)) ; Codony-Servat, Jordi (Pangaea Biotech (Barcelona, Catalunya)) ; Teixidó, Cristina (Pangaea Biotech (Barcelona, Catalunya)) ; Pilotto, Sara (University of Verona (Itàlia)) ; Drozdowskyj, Ana (Pivotal (Madrid)) ; Codony-Servat, Carles (Pangaea Biotech (Barcelona, Catalunya)) ; Giménez-Capitán, Ana (Pangaea Biotech (Barcelona, Catalunya)) ; Molina-Vila, Miguel Ángel (Pangaea Biotech (Barcelona, Catalunya)) ; Bertrán-Alamillo, Jordi (Pangaea Biotech (Barcelona, Catalunya)) ; Gervais, Radj (Centre François Baclesse (Caen, França)) ; Massuti, Bartomeu (Hospital General de Alicante) ; Morán, Teresa (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Majem, Margarita (Hospital de Sant Pau (Barcelona, Catalunya)) ; Felip Font, Enriqueta (Hospital Vall d'Hebron (Barcelona, Catalunya)) ; Carcereny, Enric (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; García-Campelo, Rosario (Complejo Hospitalario Universitario de A Coruña) ; Viteri, Santiago (Hospital Universitari Quiron Dexeus (Barcelona, Catalunya)) ; González-Cao, María (Hospital Universitari Quiron Dexeus (Barcelona, Catalunya)) ; Morales-Espinosa, Daniela (Hospital Universitari Quiron Dexeus (Barcelona, Catalunya)) ; Verlicchi, Alberto (Ospedale Santa Maria delle Croci (Ravenna, Itàlia)) ; Crisetti, Elisabetta (Institute of Respiratory Diseases. University of Foggia (Itàlia)) ; Chaib, Imane (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Santarpia, Mariacarmela (Human Pathology Department. University of Messina (Itàlia)) ; Ramírez, José Luis (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Bosch-Barrera, Joaquim (Hospital Josep Trueta, Girona. Institut Català d'Oncologia) ; Cardona Zorrilla, Andrés Felipe (Instituto de Oncología de Clínica del Country (Bogotá, Colòmbia)) ; De Marinis, Filippo (Istituto Europeo di Oncologia (Milà, Itàlia)) ; López-Vivanco, Guillermo (Hospital de Cruces (Barakaldo, Biscaia)) ; Sánchez, José Miguel (Hospital Universitario de la Princesa (Madrid)) ; Vergnenegre, Alain (Hôpital du Cluzeau (Limoges, França)) ; Sánchez Hernández, José Javier (Universidad Autónoma de Nuevo León (Mèxic)) ; Sperduti, Isabella (Istituto Regina Elena Cancer Institute (Roma, Itàlia)) ; Bria, Emilio (University of Verona (Itàlia)) ; Rosell, Rafael (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol)
Abstract. BIM is a proapoptotic protein that initiates apoptosis triggered by EGFR tyrosine kinase inhibitors (TKI). mTOR negatively regulates apoptosis and may influence response to EGFR TKI. We examined mRNA expression of BIM and MTOR in 57 patients with EGFR-mutant NSCLC from the EURTAC trial. [...]
2015 - 10.1038/srep17499
Scientific reports, Vol. 7 (December 2015)  
8.
59 p, 12.4 MB Development of a transplantable glioma tumour model from genetically engineered mice : MRI/MRS/MRSI characterisation / Ciezka, Magdalena (Universitat Autònoma de Barcelona. Departament de Bioquímica i Biologia Molecular) ; Acosta González, Milena (Universitat Autònoma de Barcelona. Departament de Bioquímica i Biologia Molecular) ; Herranz, Cristina (Universitat de Barcelona. Departament de Ciències biomèdiques) ; Canals, Josep Maria (Universitat de Barcelona. Departament de Ciències biomèdiques) ; Pumarola i Batlle, Martí (Universitat Autònoma de Barcelona. Departament de Medicina i Cirurgia Animals) ; Candiota Silveira, Ana Paula (Universitat Autònoma de Barcelona. Departament de Bioquímica i Biologia Molecular) ; Arús i Caraltó, Carles (Universitat Autònoma de Barcelona. Departament de Bioquímica i Biologia Molecular)
The initial aim of this study was to generate a transplantable glial tumour model of low-intermediate grade by disaggregation of a spontaneous tumour mass from genetically engineered models (GEM). This should result in an increased tumour incidence in comparison to GEM animals. [...]
2016 - 10.1007/s11060-016-2164-3
Journal of neuro-oncology, Vol. 129, issue 1 (Aug. 2016) , p. 67-76  
9.
8 p, 785.8 KB Mastocitoma intestinal de grado III en el perro : a propósito de un caso clínico / Carrillo Sánchez, Juana Dolores (Universidad de Murcia. Facultad de Veterinaria) ; Buendia, A. (Universidad de Murcia. Facultad de Veterinaria) ; Soler Laguía, Marta (Universidad de Murcia. Facultad de Veterinaria) ; Belda Mellado, Eiseo (Universidad de Murcia. Facultad de Veterinaria) ; Sánchez, J. (Universidad de Murcia. Facultad de Veterinaria) ; Murciano Pérez, José (Universidad de Murcia. Facultad de Veterinaria) ; Agut Giménez, Amalia (Universidad de Murcia. Facultad de Veterinaria)
Este caso clínico describe un mastocitoma intestinal de grado III en un Fox Terrier que presentaba vómitos crónicos desde hacía un año. El examen físico reveló una ligera palidez de mucosas. El análisis sanguíneo ponía de manifiesto un proceso inflamatorio. [...]
2010
Clínica veterinaria de pequeños animales: revista oficial de AVEPA, Asociación Veterinaria Española de Especialistas en Pequeños Animales, Vol. 30 Núm. 4 (2010) , p. 253-259  
10.
4 p, 111.3 KB Hidronefrosis e hidrouréter unilaterales debidos a un carcinoma indiferenciado ureteral en un perro / Pèlach, M. (Hospital Veterinari Canis (Girona, Catalunya)) ; Pons, C. (Hospital Veterinari Canis (Girona, Catalunya)) ; Movilla, R. (Hospital Veterinari Canis (Girona, Catalunya))
Una Bóxer, hembra no castrada, de ocho años de edad, se presentó en la consulta con un cuadro de cojera intermitente. En su historia clínica destacaba el diagnóstico de leishmaniosis seis meses antes, agravada por una insuficiencia renal de grado II según la clasificación IRIS. [...]
2010
Clínica veterinaria de pequeños animales : revista oficial de AVEPA, Asociación Veterinaria Española de Especialistas en Pequeños Animales, Vol. 30 Núm. 4 (2010)  

Artículos : Encontrados 11 registros   1 - 10siguiente  ir al registro:
Documentos de investigación Encontrados 5 registros  
1.
1 p, 760.4 KB Polymorphisms in p53 and cancer therapy : how does the p53-R72P polymorphism affect the treatment outcome? / Navarro Barea, Natalia ; Armengol Rosell, Gemma, dir. (Universitat Autònoma de Barcelona. Departament de Biologia Animal, de Biologia Vegetal i d'Ecologia) ; Universitat Autònoma de Barcelona. Facultat de Biociències
2015
Graduat o Graduada en Ciències Biomèdiques [832]  
2.
1 p, 366.8 KB Invariant natural killer T cells as anti-tumour immunotherapy / Segura Martínez, Laura ; Castaño García, A. Raúl, (Ángel Raúl) dir. (Universitat Autònoma de Barcelona. Departament de Biologia Cel·lular, de Fisiologia i d'Immunologia) ; Universitat Autònoma de Barcelona. Facultat de Biociències
2014
Graduat o Graduada en Ciències Biomèdiques [832]  
3.
1 p, 401.8 KB Cancer and inflammation : review on how inflammation furthers tumour development / Bosch Queralt, Mar ; Bassols Teixidó, Anna Maria, dir. (Universitat Autònoma de Barcelona. Departament de Bioquímica i Biologia Molecular) ; Universitat Autònoma de Barcelona. Facultat de Biociències
2014
Graduat o Graduada en Ciències Biomèdiques [832]  
4.
1 p, 912.1 KB Directed metastasis : breast to bone / Sanchez Piquer, Neus ; Itarte, Emili, dir. (Universitat Autònoma de Barcelona. Departament de Bioquímica i Biologia Molecular) ; Universitat Autònoma de Barcelona. Facultat de Biociències
2014
Graduat o Graduada en Bioquímica [814]  
5.
1 p, 2.1 MB Genómica comparativa : diseccionando el genoma del cáncer facial del demonio de Tasmania (DFTD) / Castelló Echeverria, Clara ; Ruiz-Herrera Moreno, Aurora, dir. (Universitat Autònoma de Barcelona. Departament de Biologia Cel·lular, de Fisiologia i d'Immunologia) ; Universitat Autònoma de Barcelona. Facultat de Biociències
2013
Graduat o Graduada en Biologia [812]  

¿Le interesa recibir alertas sobre nuevos resultados de esta búsqueda?
Defina una alerta personal vía correo electrónico o subscríbase al canal RSS.